2.4(top 20%)
impact factor
2.1K(top 10%)
papers
47.7K(top 10%)
citations
90(top 5%)
h-index
2.5(top 20%)
impact factor
2.9K
all documents
50.2K
doc citations
128(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008HIV Medicine2008530
2Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapyHIV Medicine2000399
3Late presentation of HIV infection: a consensus definitionHIV Medicine2011378
4Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta‐analysisHIV Medicine2012346
5Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyHIV Medicine2013329
6Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysisHIV Medicine2017309
7The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyHIV Medicine2006296
8Tenofovir‐associated renal and bone toxicityHIV Medicine2009275
9Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohortHIV Medicine2005258
10European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV‐infected adultsHIV Medicine2008239
11The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infectionHIV Medicine2004236
12European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adultsHIV Medicine2008222
13Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patientsHIV Medicine2017216
14A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infectionHIV Medicine2004214
15British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)HIV Medicine2006193
16European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV*HIV Medicine2008189
17Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003HIV Medicine2005186
18Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA studyHIV Medicine2003181
19HIV lipodystrophy: prevalence, severity and correlates of risk in AustraliaHIV Medicine2003181
20Diagnosed and undiagnosed HIV‐infected populations in EuropeHIV Medicine2008171
21The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapyHIV Medicine2006163
22Sexualized drug use (‘chemsex’) and high‐risk sexual behaviours in HIV‐positive men who have sex with menHIV Medicine2018163
23British HIV Association guidelines for the routine investigation and monitoring of adult HIV‐1‐infected individuals 2011HIV Medicine2012162
24Principles and practice of HIV-protease inhibitor pharmacoenhancementHIV Medicine2001159
25British HIV Association guidelines for HIV‐associated malignancies 2008HIV Medicine2008158
26Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study*HIV Medicine2011154
27Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literatureHIV Medicine2008153
28Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkersHIV Medicine2010151
29British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012HIV Medicine2012149
30Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV‐1‐infected treatment‐naïve patients in the ARTEMIS trialHIV Medicine2013149
31Long-term assessment of neuropsychiatric adverse reactions associated with efavirenzHIV Medicine2003148
32Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high‐risk men who have sex with menHIV Medicine2009145
33The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) StudyHIV Medicine2004143
34British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapyHIV Medicine2003142
35Coronavirus disease 2019 (COVID‐19) outcomes in HIV/AIDS patients: a systematic reviewHIV Medicine2020141
36Spectrum of chronic kidney disease in HIV‐infected patientsHIV Medicine2009140
37The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapyHIV Medicine2005138
38British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008HIV Medicine2008138
39PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV‐1 infectionHIV Medicine2009135
40Abacavir and risk of myocardial infarction in HIV‐infected patients on highly active antiretroviral therapy: a population‐based nationwide cohort studyHIV Medicine2010134
41HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapyHIV Medicine2003133
42Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patientsHIV Medicine2006133
43HIV/IL‐2 and EBV‐associated lymphoproliferative diseases: cause and effect or coincidence?HIV Medicine2014132
44Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyHIV Medicine2006130
45British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005)HIV Medicine2005129
46The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrationsHIV Medicine2005128
47The CD4:CD8 ratio is associated with markers of age‐associated disease in virally suppressed HIV‐infected patients with immunological recoveryHIV Medicine2014124
48Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patientsHIV Medicine2005123
49Immune activation in the course of HIV‐1 infection: Causes, phenotypes and persistence under therapyHIV Medicine2016123
50Immune deficiency is a risk factor for severe COVID‐19 in people living with HIVHIV Medicine2021123